BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18710613)

  • 1. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme].
    Li CM; Liu XG; Lin XC; Chen XW; Liang NC
    Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect and its kinetic analysis of baicalein on recombinant human protein kinase CK2 holoenzyme].
    Lin XC; Liu XG; Chen XW; Chen WZ; Liang NC
    Ai Zheng; 2004 Aug; 23(8):874-8. PubMed ID: 15301706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
    Liu XG; Liang NC
    Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of AG1109 on recombinant human protein kinase CK2 holoenzyme].
    Liu XG; Liang NC
    Ai Zheng; 2002 Feb; 21(2):153-7. PubMed ID: 12479065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect and kinetic analysis of sodium quercetin-7,4'-disulphate on recombinant human protein kinase CK2 holoenzyme].
    Liu XG; Liang NC; Liu W; She J; Mo LE
    Yao Xue Xue Bao; 2002 Mar; 37(3):165-8. PubMed ID: 12579753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase CK2 subunits are positive regulators of AKT kinase.
    Guerra B
    Int J Oncol; 2006 Mar; 28(3):685-93. PubMed ID: 16465374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
    Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z
    Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-escin, a natural triterpenoid saponin from Chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis.
    Niu YP; Wu LM; Jiang YL; Wang WX; Li LD
    J Pharm Pharmacol; 2008 Sep; 60(9):1213-20. PubMed ID: 18718126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].
    Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
    Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
    Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
    Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
    FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.
    Yamane K; Kinsella TJ
    Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells.
    Li ZM; Jiang WQ; Guan ZZ; Zhu XF; Zhou JM; Xie BF; Feng GK; Zhu ZY; Liu ZC
    Yao Xue Xue Bao; 2006 Oct; 41(10):978-84. PubMed ID: 17184117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.